AI-Assisted Endoscopy for Upper Aerodigestive Tract Lesions

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorIstituto Italiano di Tecnologia

About this trial

This is a prospective observational clinical study designed to evaluate the performance of artificial intelligence (AI) algorithms applied to upper aerodigestive tract (UADT) video-endoscopy. The study assesses three main tasks: lesion detection (localization), classification (benign vs malignant), and segmentation of tumor margins.

AI algorithms will be applied to endoscopic video data acquired during routine clinical practice without influencing clinical decision-making. The system will process images in real time and store data for subsequent analysis. AI outputs will be compared with physician assessment and reference standard histopathology to evaluate diagnostic performance.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age > 18 years

Injury originating from the upper aero-digestive tract

Recording of the video-endoscopic examination

Patient known to undergo a biopsy of the lesion or clinical follow-up for lesion with known biopsy (e.g. laryngeal papillomatosis) or suffering from Reinke's edema (in this pathology, in fact, biopsy is not necessary since the diagnosis is clinical)

Disqualifiers

Submucosal lesion

Patients with previous operations on the upper aero-digestive tract

Patients with previous radiotherapy of the head and neck district

Poor compliance on endoscopic examination

Trial population

The sample size for a single-arm, prospective cohort study, where the same group of patients undergoes testing with an AI model and a human physician and then they are compared with the gold standard reference test (biopsy) was calculated based on information from previous studies

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Trial outcomes

Primary outcomes

1

Negative Predictive Value of the CADx Algorithm for Malignant or Premalignant Upper Aerodigestive Tract Lesions

Negative Predictive Value (NPV) of the computer-aided diagnosis (CADx) algorithm for classifying UADT lesions as malignant/premalignant versus benign/non-neoplastic, using definitive histopathology as the reference standard. The CADx final classification will be based on the majority rule across selected white-light and narrow-band imaging frames. NPV = true negatives / (true negatives + false negatives). The pre-specified performance target is NPV ≥ 90%.

Time frame
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
2

Sensitivity of the CADe Algorithm for Localization of Upper Aerodigestive Tract Lesions

Sensitivity of the computer-aided detection (CADe) algorithm for localizing UADT lesions with a bounding box. A true positive is defined as localization of the lesion area by a bounding box in the majority of physician-labeled lesion-positive captured frames. Sensitivity = true positives / (true positives + false negatives).

Time frame
At index outpatient UADT video-endoscopy, with blinded post-processing assessment performed up to 30 days after endoscopy.
3

Median Intersection Over Union Between CASe Segmentation and Surgeon-Drawn Lesion Margins

Median overlap between the AI-generated segmentation mask and the lesion margin area drawn by the surgeon on intraoperative endoscopic images. Intersection over Union (IoU) = area of overlap / area of union. Values range from 0 to 1; higher values indicate greater agreement.

Time frame
At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.
4

Median Dice Similarity Coefficient Between CASe Segmentation and Surgeon-Drawn Lesion Margins

Median Dice Similarity Coefficient (DSC) between the AI-generated segmentation mask and the lesion margin area drawn by the surgeon on intraoperative endoscopic images. Dice Similarity Coefficient = 2 × area of overlap / (AI segmented area + surgeon-drawn area). Values range from 0 to 1; higher values indicate greater agreement.

Time frame
At intraoperative pre-resection endoscopy, with assessment performed after image annotation up to 30 days after surgery.

Secondary outcomes

1

WL-NPV vs. NBI-NPV of CADx classification

Negative Predictive Value (NPV) of CADx classification calculated using only the three selected white-light frames, compared with definitive histopathology, vs. NPV of CADx classification calculated using only the three selected narrow-band imaging frames, compared with definitive histopathology. The final AI-result will be calculated based on the majority rule of the 3 WL and 3 NBI frames computed separately.

Time frame
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
2

Clinician-Reported Usability Score for the AI Endoscopy System

Usability of the AI endoscopy system assessed using standardized usability questionnaires administered to clinicians after use of the AI system. Questionnaire scoring will be interpreted according to the selected questionnaire manual, with higher scores indicating greater usability.

Time frame
Assessed after clinician use of the AI system during study procedures, up to 20 months after study initiation.
3

Sensitivity, Specificity and Accuracy of CADx histology prediction

Sensitivity, Specificity and Accuracy of the CADx algorithm for histology prediction, compared with definitive histopathology.

Time frame
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.
4

F1 Score of CADx Classification

F1 score of the CADx classification output compared with definitive histopathology.

Time frame
From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Istituto Italiano di Tecnologia

Lead sponsor

Hospital Clinic of Barcelona

Collaborator

CRO "Centro Clinical Trials" IRCCS Ospedale Policlinico San Martino

Collaborator

Universitaire Ziekenhuizen KU Leuven

Collaborator

Università degli Studi 'G. d'Annunzio' Chieti e Pescara

Collaborator

Universita degli Studi di Genova

Collaborator

Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna

Collaborator

This trial is not recruiting at the moment. You can still explore other options: